In vitro fertilization practice in patients with absolute uterine factor undergoing uterus transplant in the United States
- PMID: 38631504
- DOI: 10.1016/j.fertnstert.2024.04.017
In vitro fertilization practice in patients with absolute uterine factor undergoing uterus transplant in the United States
Abstract
Objective: To report detailed, pooled multicenter experiences and outcomes after in vitro fertilization (IVF) treatment among patients undergoing uterus transplantation (UTx) in the US.
Design: Cohort study.
Setting: Hospital.
Patients: Patients undergoing UTxsfrom the three longest-running UTx clinical trials in the US.
Intervention: In vitro fertilization treatment among patients undergoing UTx.
Main outcome measures: Reproductive outcomes pretransplant and posttransplant ovarian stimulation.
Results: Thirty-one uterus transplant recipients were included in this cohort (mean [±SD] age at transplant was 31 ± 4.7 years). Before transplant, recipients completed a mean of two oocyte retrievals (range 1-4), banking a mean of eight untested embryos (range 3-24) or six euploid embryos (range 2-10). Posttransplant retrieval cycles were required in 19% (n = 6/31) of recipients, for a total of 16 cycles (range 2-4 cycles per recipient). All posttransplant retrievals were performed vaginally without complications. Preimplantation genetic testing was used by 74% (n = 23/31) of subjects. Seventy-two autologous single embryo transfers (ETs) occurred in 23 patients who completed at least one ET. Two ETs followed a fresh IVF treatment cycle, and the remainder (n = 70) were frozen ETs. Endometrial preparation was more commonly performed with programmed protocols (n = 61) (exogenous administration of estrogen and progesterone) compared with natural cycle protocols (n = 9). The overall live birth rate (LBR) for this cohort was 35% (n = 25/72) per ET. Among those patients (n = 21) who had an ET leading to a live birth, a mean of 2.2 ETs were performed. The overall LBR after the first ET was 57% (n = 13/23) and rose to 74% (n = 17/23) after a second ET. There was no difference in rate of preeclampsia, live birth, neonatal birth, or placental weights among programmed vs. natural cycle frozen ETs. There were no differences in the LBR between living or deceased donor uteri (37% vs. 32%).
Conclusions: Posttransplant ovarian stimulation was required in 26% (n = 6/23) of recipients undergoing at least one ET, despite high rates of preimplantation genetic testing and pretransplant embryo cryopreservation. Posttransplant retrievals were performed transvaginally, without complications. Future reporting of IVF treatment experiences will be essential to optimizing reproductive outcomes after a uterus transplant.
Clinical trial registration numbers: NCT02656550 (Baylor University Medical Center); NCT03307356 (University of Pennsylvania); and NCT02573415 (Cleveland Clinic).
Keywords: Uterus transplant; absolute uterine factor infertility; infertility; in vitro fertilization.
Copyright © 2024 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Interests J.R.W. has nothing to disclose. L.J. has nothing to disclose. T.F. has nothing to disclose. M.P. has nothing to disclose. G.T. has nothing to disclose. E.G.R. has nothing to disclose. K.E.O has nothing to disclose.
Similar articles
-
Does endometrial thickness impact live birth rate following a frozen embryo transfer: outcomes of 30 676 euploid single embryo transfers.Hum Reprod. 2025 Jul 10:deaf129. doi: 10.1093/humrep/deaf129. Online ahead of print. Hum Reprod. 2025. PMID: 40639807
-
Cycle regimens for frozen-thawed embryo transfer.Cochrane Database Syst Rev. 2017 Jul 5;7(7):CD003414. doi: 10.1002/14651858.CD003414.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2025 Jun 3;6:CD003414. doi: 10.1002/14651858.CD003414.pub4. PMID: 28675921 Free PMC article. Updated.
-
Intrauterine administration of human chorionic gonadotropin (hCG) for subfertile women undergoing assisted reproduction.Cochrane Database Syst Rev. 2016 May 20;(5):CD011537. doi: 10.1002/14651858.CD011537.pub2. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2018 Oct 20;10:CD011537. doi: 10.1002/14651858.CD011537.pub3. PMID: 27195724 Updated.
-
In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction.Cochrane Database Syst Rev. 2025 Feb 6;2(2):CD006606. doi: 10.1002/14651858.CD006606.pub5. Cochrane Database Syst Rev. 2025. PMID: 39912435
-
Oral medications including clomiphene citrate or aromatase inhibitors with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilisation.Cochrane Database Syst Rev. 2017 Nov 2;11(11):CD008528. doi: 10.1002/14651858.CD008528.pub3. Cochrane Database Syst Rev. 2017. PMID: 29096046 Free PMC article.
Cited by
-
Comparing gestational carrier with uterine transplantation in uterine-factor infertility: a cost-effectiveness analysis.Fertil Steril. 2025 Jul;124(1):134-143. doi: 10.1016/j.fertnstert.2025.01.012. Epub 2025 Jan 22. Fertil Steril. 2025. PMID: 39848421
-
Uterine Transplantation: Advances, Challenges, and Future Perspectives.Diseases. 2025 May 15;13(5):152. doi: 10.3390/diseases13050152. Diseases. 2025. PMID: 40422584 Free PMC article. Review.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical